Illumina Ventures Closes $230 Million FundGenomics-focused fund will support breakthroughs in life science research, clinical diagnostics, novel therapeutic platforms, and other technologies impacting human health
SAN FRANCISCO, October 16, 2017-- Illumina Ventures, an independent, early-stage venture capital firm, announced today that it has raised $230 million for its first fund. Illumina Ventures was launched in the summer of 2016 with an initial $100 million investment from Illumina. The balance of the funds have been raised from a mix of corporate, institutional, sovereign, and individual investors.